Tech Company Financing Transactions
Enhanc3D Genomics Funding Round
On 10/20/2022, Enhanc3D Genomics announced $11.3 million in Series A financing from BGF Ventures, Bioqube Ventures and ParkWalk Advisors.
Transaction Overview
Company Name
Announced On
10/20/2022
Transaction Type
Venture Equity
Amount
$11,300,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its proprietary technology platform "GenLink3D", also expand its team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Jeffreys Building, Unit 1 St John's Innovation Park, Cowley
Cambridge, CB4 0WS
UK
Cambridge, CB4 0WS
UK
Phone
Undisclosed
Website
Email Address
Overview
Developing an unparalleled platform integrating proprietary molecular biology technologies with machine learning to maximise the commercial potential of 3D genomics. Enhanc3D Genomics was spun out from the laboratories of Dr. Stefan Schoenfelder and Professor Peter Fraser, who pioneered research into the dynamic spatial organisation of the genome at the Babraham Institute in Cambridge, UK.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Debora Lucarelli
Chief Financial Officer
Peter Bream
Browse more venture capital transactions:
Prev: 10/20/2022: Ventive venture capital transaction
Next: 10/20/2022: The New Computer venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs